» Articles » PMID: 34307295

α-Synuclein: An All-Inclusive Trip Around Its Structure, Influencing Factors and Applied Techniques

Overview
Journal Front Chem
Specialty Chemistry
Date 2021 Jul 26
PMID 34307295
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Alpha-synuclein (αSyn) is a highly expressed and conserved protein, typically found in the presynaptic terminals of neurons. The misfolding and aggregation of αSyn into amyloid fibrils is a pathogenic hallmark of several neurodegenerative diseases called synucleinopathies, such as Parkinson's disease. Since αSyn is an Intrinsically Disordered Protein, the characterization of its structure remains very challenging. Moreover, the mechanisms by which the structural conversion of monomeric αSyn into oligomers and finally into fibrils takes place is still far to be completely understood. Over the years, various studies have provided insights into the possible pathways that αSyn could follow to misfold and acquire oligomeric and fibrillar forms. In addition, it has been observed that αSyn structure can be influenced by different parameters, such as mutations in its sequence, the biological environment (e.g., lipids, endogenous small molecules and proteins), the interaction with exogenous compounds (e.g., drugs, diet components, heavy metals). Herein, we review the structural features of αSyn (wild-type and disease-mutated) that have been elucidated up to present by both experimental and computational techniques in different environmental and biological conditions. We believe that this gathering of current knowledge will further facilitate studies on αSyn, helping the planning of future experiments on the interactions of this protein with targeting molecules especially taking into consideration the environmental conditions.

Citing Articles

Refining α-synuclein seed amplification assays to distinguish Parkinson's disease from multiple system atrophy.

Wiseman J, Turner C, Faull R, Halliday G, Dieriks B Transl Neurodegener. 2025; 14(1):7.

PMID: 39920796 PMC: 11804046. DOI: 10.1186/s40035-025-00469-6.


Ordered Aggregates of Fmoc-Diphenylalanine at Alkaline pH as a Precursor of Fibril Formation and Peptide Gelation.

Hughes E, ONeill N, Schweitzer-Stenner R J Phys Chem B. 2024; 129(1):260-272.

PMID: 39710982 PMC: 11726616. DOI: 10.1021/acs.jpcb.4c06796.


Strategies of positron emission tomography (PET) tracer development for imaging of tau and α-synuclein in neurodegenerative disorders.

Mekala S, Wu Y, Li Y RSC Med Chem. 2024; .

PMID: 39678127 PMC: 11638850. DOI: 10.1039/d4md00576g.


Liquid-liquid phase separation and conformational strains of -Synuclein: implications for Parkinson's disease pathogenesis.

Ruiz-Ortega E, Wilkaniec A, Adamczyk A Front Mol Neurosci. 2024; 17:1494218.

PMID: 39507104 PMC: 11537881. DOI: 10.3389/fnmol.2024.1494218.


Alpha Synuclein Toxicity and Non-Motor Parkinson's.

Mazzotta G, Conte C Cells. 2024; 13(15.

PMID: 39120295 PMC: 11311369. DOI: 10.3390/cells13151265.


References
1.
Ibrahim T, McLaurin J . α-Synuclein aggregation, seeding and inhibition by scyllo-inositol. Biochem Biophys Res Commun. 2015; 469(3):529-34. DOI: 10.1016/j.bbrc.2015.12.043. View

2.
Sezgin E, Levental I, Mayor S, Eggeling C . The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol. 2017; 18(6):361-374. PMC: 5500228. DOI: 10.1038/nrm.2017.16. View

3.
Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997; 276(5321):2045-7. DOI: 10.1126/science.276.5321.2045. View

4.
Shvadchak V, Falomir-Lockhart L, Yushchenko D, Jovin T . Specificity and kinetics of alpha-synuclein binding to model membranes determined with fluorescent excited state intramolecular proton transfer (ESIPT) probe. J Biol Chem. 2011; 286(15):13023-32. PMC: 3075648. DOI: 10.1074/jbc.M110.204776. View

5.
Chidananda A, Sharma A, Khandelwal R, Sharma Y . Secretagogin Binding Prevents α-Synuclein Fibrillation. Biochemistry. 2019; 58(46):4585-4589. DOI: 10.1021/acs.biochem.9b00656. View